BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32392660)

  • 1. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs.
    Park TY; Oh HC; Fogel EL; Lehman GA
    Korean J Intern Med; 2020 May; 35(3):535-543. PubMed ID: 32392660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
    Parsi MA
    World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
    Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
    J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
    Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low dose rectal diclofenac for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score-matched analysis.
    Tomoda T; Kato H; Miyamoto K; Matsumi A; Ueta E; Fujii Y; Saragai Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Okada H
    Dig Endosc; 2021 May; 33(4):656-662. PubMed ID: 32881078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta-analysis.
    Shen C; Shi Y; Liang T; Su P
    Dig Endosc; 2017 May; 29(3):281-290. PubMed ID: 28112441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
    Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
    Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Avoid Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Leerhøy B; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2018 Oct; 28(4):439-454. PubMed ID: 30241637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
    Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
    Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal Nonsteroidal Anti-inflammatory Drugs for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis: A Case Study in a Price-Escalation Era.
    McKee K; Singh VK; Akshintala VS
    Gastroenterology; 2022 Sep; 163(3):543-546. PubMed ID: 35598627
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis.
    Hou YC; Hu Q; Huang J; Fang JY; Xiong H
    Sci Rep; 2017 Apr; 7():46650. PubMed ID: 28440297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy: can rectal NSAIDs prevent post-ERCP pancreatitis?
    Testoni PA
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):429-30. PubMed ID: 22710572
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
    Tammaro S; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2012 Sep; 18(34):4635-8. PubMed ID: 23002332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
    Cheon YK
    Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
    Lua GW; Muthukaruppan R; Menon J
    Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.